Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $990,671 - $1.29 Million
4,800 Added 252.63%
6,700 $1.38 Million
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $203,520 - $273,430
-1,000 Reduced 34.48%
1,900 $514,000
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $329,040 - $477,680
-2,000 Reduced 40.82%
2,900 $685,000
Q3 2023

Nov 15, 2023

BUY
$194.44 - $217.61 $155,552 - $174,088
800 Added 19.51%
4,900 $960,000
Q2 2023

Aug 23, 2023

BUY
$183.71 - $210.25 $753,211 - $862,025
4,100 New
4,100 $862,000
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $413,931 - $525,147
2,100 Added 80.77%
4,700 $1.02 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $492,588 - $676,458
-2,700 Reduced 50.94%
2,600 $494,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $489,912 - $725,760
-2,400 Reduced 31.17%
5,300 $1.16 Million
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $2.76 Million - $3.91 Million
-10,800 Reduced 58.38%
7,700 $2.23 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $140,552 - $179,472
-400 Reduced 2.12%
18,500 $6.95 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $4.88 Million - $6 Million
13,100 Added 225.86%
18,900 $8 Million
Q2 2021

Aug 06, 2021

BUY
$294.17 - $371.65 $735,425 - $929,125
2,500 Added 75.76%
5,800 $2.16 Million
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $798,944 - $958,336
-3,200 Reduced 49.23%
3,300 $950,000
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $155,400 - $176,834
-700 Reduced 9.72%
6,500 $1.62 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $3.09 Million - $3.99 Million
-17,600 Reduced 70.97%
7,200 $1.61 Million
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $2.13 Million - $3.4 Million
17,900 Added 259.42%
24,800 $4.19 Million
Q1 2020

May 11, 2020

SELL
$98.9 - $178.34 $148,350 - $267,510
-1,500 Reduced 17.86%
6,900 $897,000
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $1.05 Million - $1.21 Million
8,400 New
8,400 $1.11 Million
Q3 2018

Nov 14, 2018

SELL
$112.11 - $134.54 $605,394 - $726,516
-5,400 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$98.19 - $115.2 $648,054 - $760,320
-6,600 Reduced 55.0%
5,400 $576,000
Q4 2017

Feb 14, 2018

BUY
$100.43 - $118.09 $1.21 Million - $1.42 Million
12,000
12,000 $1.31 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.